Stocks and Investing Stocks and Investing
Mon, January 6, 2014
Sun, January 5, 2014
Fri, January 3, 2014
Thu, January 2, 2014
Tue, December 31, 2013
Fri, December 27, 2013
Tue, December 24, 2013
Mon, December 23, 2013

Matthew Kaplan Upgraded (UTHR) to Strong Buy and Held Target at $138 on, Dec 23rd, 2013


Published on 2024-10-25 03:55:59 - WOPRAI, Matthew Kaplan
  Print publication without navigation


Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy and Held Target at $138 on, Dec 23rd, 2013.

Matthew, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources